Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai
Avant Technologies (OTCQB:AVAI) announced that Vinicio Vargas, CEO of their joint venture partner Ainnova Tech and board member of Ai-nova Acquisition Corp (AAC), will be a featured speaker at the 2025 AI Revolution in Healthcare Summit in Dubai on February 15-16.
Vargas will address experts and investors about the clinical adoption of AI in healthcare, focusing on how it improves diagnostics and expands access to underserved communities. His presentation will cover key adoption drivers like investments in telemedicine and AI-powered imaging, while discussing challenges in data standardization, regulatory compliance, and workforce training.
As a panelist, he will participate in discussions about ethics in healthcare AI deployment, including data privacy, algorithmic bias, transparency in AI decision-making, and regulatory compliance across regions.
Avant Technologies (OTCQB:AVAI) ha annunciato che Vinicio Vargas, CEO del loro partner di joint venture Ainnova Tech e membro del consiglio di Ai-nova Acquisition Corp (AAC), sarà uno dei relatori principali al 2025 AI Revolution in Healthcare Summit a Dubai il 15-16 febbraio.
Vargas si rivolge a esperti e investitori riguardo all'adozione clinica dell'IA nella sanità, concentrandosi su come migliora le diagnosi e amplia l'accesso per le comunità svantaggiate. La sua presentazione affronterà i principali fattori di adozione come gli investimenti nella telemedicina e nell'imaging potenziato dall'IA, discutendo anche le sfide nella standardizzazione dei dati, nella conformità normativa e nella formazione della forza lavoro.
In qualità di panelista, parteciperà a discussioni sull'etica nell'implementazione dell'IA nella sanità, inclusi la privacy dei dati, i pregiudizi algoritmici, la trasparenza nella decisione dell'IA e la conformità normativa tra le diverse regioni.
Avant Technologies (OTCQB:AVAI) anunció que Vinicio Vargas, CEO de su socio de joint venture Ainnova Tech y miembro de la junta de Ai-nova Acquisition Corp (AAC), será uno de los oradores destacados en el 2025 AI Revolution in Healthcare Summit en Dubái del 15 al 16 de febrero.
Vargas se dirigirá a expertos e inversores sobre la adopción clínica de la IA en la atención médica, centrándose en cómo mejora los diagnósticos y amplía el acceso a comunidades desatendidas. Su presentación cubrirá los principales impulsores de adopción, como las inversiones en telemedicina y en imágenes potenciadas por IA, mientras discute los desafíos en la estandarización de datos, el cumplimiento normativo y la formación de la fuerza laboral.
Como panelista, participará en discusiones sobre la ética en la implementación de IA en la atención médica, incluyendo la privacidad de datos, el sesgo algorítmico, la transparencia en la toma de decisiones de IA y el cumplimiento normativo en diferentes regiones.
Avant Technologies (OTCQB:AVAI)는 합작 투자 파트너인 Ainnova Tech의 CEO이자 Ai-nova Acquisition Corp (AAC)의 이사인 Vinicio Vargas가 2월 15-16일 두바이에서 열리는 2025 AI Revolution in Healthcare Summit의 주요 연사로 초청되었다고 발표했습니다.
Vargas는 의료 분야에서의 AI의 임상 채택에 대해 전문가와 투자자들에게 연설하며, AI가 어떻게 진단을 개선하고 소외된 커뮤니티에 대한 접근을 확대하는지에 중점을 둘 것입니다. 그의 발표는 원격 의료와 AI 기반 이미징에 대한 투자와 같은 주요 채택 요인을 다루고, 데이터 표준화, 규제 준수 및 인력 교육의 도전 과제에 대해서도 논의할 것입니다.
패널리스트로서 그는 의료 AI 배치의 윤리에 관한 논의에 참여하며, 데이터 개인 정보 보호, 알고리즘 편향, AI 의사 결정의 투명성, 그리고 지역 간의 규제 준수 등을 포함할 것입니다.
Avant Technologies (OTCQB:AVAI) a annoncé que Vinicio Vargas, PDG de leur partenaire de coentreprise Ainnova Tech et membre du conseil d'administration d'Ai-nova Acquisition Corp (AAC), sera l'un des intervenants principaux au 2025 AI Revolution in Healthcare Summit à Dubaï les 15 et 16 février.
Vargas s'adressera à des experts et des investisseurs sur l'adoption clinique de l'IA dans le secteur de la santé, en se concentrant sur la manière dont elle améliore les diagnostics et élargit l'accès aux communautés mal desservies. Sa présentation couvrira les principaux moteurs d'adoption tels que les investissements dans la télémédecine et l'imagerie alimentée par l'IA, tout en discutant des défis liés à la normalisation des données, à la conformité réglementaire et à la formation de la main-d'œuvre.
En tant que membre du panel, il participera aux discussions sur l'éthique du déploiement de l'IA dans le secteur de la santé, y compris la confidentialité des données, les biais algorithmiques, la transparence dans la prise de décision par l'IA et la conformité réglementaire entre les différentes régions.
Avant Technologies (OTCQB:AVAI) gab bekannt, dass Vinicio Vargas, CEO ihres Joint-Venture-Partners Ainnova Tech und Mitglied des Vorstands von Ai-nova Acquisition Corp (AAC), als Hauptredner beim 2025 AI Revolution in Healthcare Summit in Dubai am 15.-16. Februar auftreten wird.
Vargas wird Experten und Investoren über die klinische Einführung von KI im Gesundheitswesen informieren und dabei den Fokus auf die Verbesserung von Diagnosen und die Erweiterung des Zugangs für benachteiligte Gemeinschaften legen. Seine Präsentation wird wichtige Treiber der Einführung wie Investitionen in Telemedizin und KI-gestützte Bildgebung behandeln und Herausforderungen in der Datenstandardisierung, der Einhaltung von Vorschriften und der Schulung der Arbeitskräfte diskutieren.
Als Panelist wird er an Diskussionen über die Ethik bei der Implementierung von KI im Gesundheitswesen teilnehmen, einschließlich Datenschutz, algorithmischer Voreingenommenheit, Transparenz in der KI-Entscheidungsfindung und der Einhaltung von Vorschriften in verschiedenen Regionen.
- None.
- None.
LAS VEGAS, NEVADA / ACCESS Newswire / February 13, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Vinicio Vargas, the co-founder and Chief Executive Officer of Ainnova and member of the board of directors for Ai-nova Acquisition Corp. (AAC), a joint venture formed by both companies, will be a highlighted speaker at the 2025 AI Revolution in Healthcare Summit in Dubai, UAE, on February 15-16.
Vargas, who is spearheading the success of AAC in the AI healthcare industry, will speak to an audience of experts and investors in AI on the clinical adoption of AI and how it is transforming healthcare, improving diagnostics, and expanding access to underserved communities. He will introduce the key drivers of AI adoption, including growing investments in telemedicine and AI-powered imaging, discuss the challenges that remain in data standardization, regulatory compliance, and workforce training, and speak to the importance of collaboration among governments, providers, and tech leaders, which he says is vital for equitable AI integration.
While attending the Summit, Vargas will offer his expertise in the industry as a panelist. He will make up a panel of experts that will explore a range of topics on the ethics in deploying AI in healthcare settings, including:
Data Privacy and Security: Ensuring patient confidentiality and safeguarding sensitive information in AI applications.
Bias and Fairness: Addressing potential biases in AI algorithms to promote equitable healthcare outcomes.
Transparency and Accountability: Maintaining clarity in AI decision-making processes and establishing responsibility for AI-driven outcomes.
Regulatory Compliance: Navigating the legal frameworks governing AI deployment in healthcare across different regions.
To learn more about the 2025 AI Revolution in Healthcare Summit in Dubai, visit: https://events.assimilate.one/AI-Revolution-in-Healthcare-Dubai-2025#/?lang=en
About Ainnova Tech, Inc.
Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce VisionAI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.
About Avant Technologies, Inc.
Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.
More information about Avant can be found at https://avanttechnologies.com
You can also follow us on social media at:
https://twitter.com/AvantTechAI https://www.linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the
Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.
Contact:
Avant Technologies, Inc.
info@avanttechnologies.com
SOURCE: Avant Technologies
View the original press release on ACCESS Newswire
FAQ
What will Vinicio Vargas discuss at the 2025 AI Revolution in Healthcare Summit in Dubai?
What ethical topics will be covered in the AI healthcare panel featuring AVAI's joint venture partner?
When and where is Avant Technologies' (AVAI) joint venture partner speaking at the AI Healthcare Summit?
What is the relationship between Avant Technologies (AVAI) and Ainnova Tech?
